Assert-IQ vs Caption Guidance

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott Medical

Caption Guidance

by Caption Health

AI Verdict

Assert-IQ specializes in long-term, continuous monitoring of heart rhythms to detect and manage arrhythmias through an insertable cardiac monitor. In contrast, Caption Guidance focuses on real-time AI guidance for acquiring diagnostic-quality cardiac ultrasound images. While both are cardiology AI tools, they address distinct diagnostic needs: rhythm disorder surveillance versus enhanced cardiac imaging acquisition.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous monitoring for patients with suspected or intermittent heart rhythm disorders that may not be captured by shorter-term diagnostic methods. This tool is ideal for comprehensive arrhythmia detection and remote management over several years, providing proactive alerts and patient-activated symptom logging.

View Assert-IQ →

Choose Caption Guidance if…

Choose Caption Guidance if your goal is to empower a broader range of healthcare providers to acquire high-quality cardiac ultrasound images, even without extensive sonography expertise. This AI-guided software is best suited for enhancing access to critical cardiac diagnostics by providing real-time guidance and automated quality assessment during ultrasound examinations.

View Caption Guidance →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Caption Guidance
Pricing	Enterprise	Unknown
Deployment	Hybrid	On-premise (integrated with ultrasound equipment) and cloud-based services.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Caption Guidance

Caption Guidance directly enhances the usability of a complex diagnostic procedure by providing real-time AI guidance and automated quality assessment during ultrasound acquisition, making it more accessible and consistent for clinicians. Assert-IQ, while offering remote monitoring, primarily focuses on passive data collection and review, which is less about direct procedural usability.

Clinical Value

Assert-IQ

Assert-IQ provides unique, long-term continuous cardiac monitoring for up to 6 years, enabling the detection of intermittent arrhythmias that might otherwise be missed, directly impacting diagnosis and management of heart rhythm disorders. While Caption Guidance improves the quality and accessibility of ultrasound imaging, Assert-IQ offers a distinct and extended physiological data stream that can be critical for elusive conditions.

Pricing & Value

Tie

Both tools utilize an enterprise pricing model, requiring direct contact with the vendor for specific institutional pricing, and neither offers a free trial for their core enterprise software. The lack of transparent pricing details for either product makes a direct comparison of their value proposition impossible.

Enterprise Readiness

Tie

Both Assert-IQ and Caption Guidance are FDA-cleared, HIPAA compliant, and designed for enterprise deployment within healthcare systems. Assert-IQ explicitly targets large health systems and offers data export, while Caption Guidance integrates seamlessly with compatible existing ultrasound systems, demonstrating robust readiness for institutional adoption.

Innovation

Caption Guidance

Caption Guidance is highlighted as the 'first FDA-cleared AI-guided software' for acquiring diagnostic-quality cardiac ultrasound images, representing a significant innovation in democratizing and standardizing a complex diagnostic procedure through real-time AI. Assert-IQ, while offering advanced features like extended monitoring duration, represents an evolution of existing insertable cardiac monitor technology.

Support & Docs

Tie

Both Abbott Medical and GE HealthCare (Caption Health's parent company) are established medical device manufacturers known for providing comprehensive support, training, and documentation for their professional products. Without specific comparative details on the breadth or quality of their respective support offerings, it is not possible to determine a definitive winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Caption Guidance
Product Name	Assert-IQ	Caption Guidance
Primary Function	Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	AI-guided software that empowers healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time guidance and automated quality assessment.
Company	Abbott Medical	Caption Health (now part of GE HealthCare)
Tagline	Advanced, long-term insertable cardiac monitoring for comprehensive arrhythmia detection.	Empowering Clinicians with AI-Guided Cardiac Ultrasound
Key Feature: Core Technology	Long-term continuous cardiac monitoring (up to 6 years) with advanced arrhythmia detection algorithms.	Real-time AI guidance for ultrasound probe manipulation.
Key Feature: Data/Quality	Remote monitoring capabilities and patient activator for symptom logging.	Automated quality assessment with a 'Quality Meter' and auto-capture of diagnostic-quality ultrasound clips.

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Caption Guidance.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of each tool?

Assert-IQ is an Insertable Cardiac Monitor (ICM) system designed for long-term, continuous monitoring and advanced arrhythmia detection to aid in diagnosing and managing patients with suspected heart rhythm disorders. Caption Guidance is AI-guided software that empowers healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time guidance and automated quality assessment, enhancing access to critical cardiac diagnostics.

How do Assert-IQ and Caption Guidance differ in their technological approach to cardiac care?

Assert-IQ utilizes a minimally invasive insertable device for continuous electrical heart rhythm monitoring for up to six years, transmitting data via Bluetooth to a secure cloud platform. In contrast, Caption Guidance is a software accessory that integrates with compatible general-purpose diagnostic ultrasound systems, providing real-time AI guidance for probe manipulation and automated quality assessment during cardiac ultrasound imaging.

What specific data or insights does each tool provide to clinicians?

Assert-IQ provides advanced arrhythmia detection algorithms, remote monitoring capabilities, proactive clinician alerts, and allows patients to log symptoms. Caption Guidance offers real-time AI guidance for ultrasound probe manipulation, automated quality assessment with a 'Quality Meter', auto-capture of diagnostic-quality ultrasound clips, and automated ejection fraction calculation.

For which patient populations or conditions are these tools primarily intended?

Assert-IQ is intended for patients with suspected heart rhythm disorders, offering long-term monitoring for conditions like atrial fibrillation and unexplained symptoms. Caption Guidance enhances access to critical cardiac diagnostics by assisting healthcare providers in acquiring diagnostic-quality cardiac ultrasound images, which can be used for various cardiac conditions.